JP Pharmaceuticals

Takeda Pharmaceutical Co Ltd (4502)

Track

Track

Takeda Pharmaceutical experienced significant insider trading activity recently, with 39 transactions totaling approximately 26.67 million dollars in sales. Key executives, including the President of R&D and the Chief Transformation Officer, executed multiple planned divestments. These consistent sell-side movements occurred without any corresponding open-market purchases, reflecting a period of notable liquidity events among leadership.
Ticker: 4502 Exchange: TYO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Duprey Lauren Rusckowski Chief Transformation Officer Officer
Transaction date
Sale
Price
456.17
Quantity 72,868 -24.6%
Value US$1,726,405
Lauren Rusckowski Duprey Chief Transformation Officer Officer
Transaction date
Proposed sale
Price
250.66
Quantity 91,377
Value US$4,551,337
Plump Andrew Stewart President, R&D Executive Director
Transaction date
Planned sale
Price
250.92
Quantity 68,583 +3.6%
Value US$3,511,874
Plump Andrew Stewart Officer Officer
Transaction date
Proposed sale
Price
18.49
Quantity 1,000
Value US$100,000
Plump Andrew Stewart President, R&D Executive Director
Transaction date
Planned sale
Price
18.49
Quantity 19,651 -7.0%
Value US$363,347
Plump Andrew Stewart Officer Officer
Transaction date
Proposed sale
Price
18.49
Quantity 19,651
Value US$363,348
Greenway Nicola Deidre Petal Chief Human Resources Officer Officer
Transaction date
Sale
Price
18.11
Quantity 12,980 -24.5%
Value US$235,118
Nicola Greenway Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
17.39
Quantity 12,980
Value US$225,722
Shannon Elaine Mary Pres., Global Supply & Quality Officer
Transaction date
Sale
Price
17.55
Quantity 20,363 -23.2%
Value US$357,371
Elaine Shannon President, Global Supply & Quality
Transaction date
Proposed sale
Price
17.45
Quantity 20,363
Value US$355,334
Ibrahim Ramy Riad Ahmed President, PDT BU Officer
Transaction date
Sale
Price
17.10
Quantity 7,277 -6.6%
Value US$124,437
Duprey Lauren Rusckowski Chief Transformation Officer Officer
Transaction date
Sale
Price
17.10
Quantity 47,586 -17.4%
Value US$813,721
Pacheco Rhonda Janice President, U.S. Business Unit Officer
Transaction date
Sale
Price
17.10
Quantity 16,901 -8.5%
Value US$289,007
Plump Andrew Stewart President, R&D Executive Director
Transaction date
Sale
Price
17.10
Quantity 165,393 -17.7%
Value US$2,828,220
Pignagnoli Agosti Marcello Head, Strat. & Port. Dev Officer
Transaction date
Sale
Price
17.10
Quantity 22,957 -11.5%
Value US$392,565
Bitetti Teresa Marie President, OBU Officer
Transaction date
Sale
Price
17.10
Quantity 50,012 -16.6%
Value US$855,205
Shannon Elaine Mary Pres., Global Supply & Quality Officer
Transaction date
Sale
Price
17.10
Quantity 3,978 -5.9%
Value US$68,024
Ricci Gabriele Chief Data & Tech. Officer Officer
Transaction date
Sale
Price
17.10
Quantity 25,088 -12.8%
Value US$429,005
Platford Giles Richard President, IBU Officer
Transaction date
Sale
Price
17.10
Quantity 31,083 -9.0%
Value US$531,519
Kim Julie So-Young President and CEO Executive Director
Transaction date
Sale
Price
17.10
Quantity 89,090 -18.5%
Value US$1,523,439
Furney Natalie Anne Marie Global General Counsel Officer
Transaction date
Sale
Price
17.10
Quantity 30,868 -13.1%
Value US$527,843
Greenway Nicola Deidre Petal Chief Human Resources Officer Officer
Transaction date
Sale
Price
17.51
Quantity 33,628 -36.0%
Value US$588,715
Greenway Nicola Deidre Petal Chief Human Resources Officer Officer
Transaction date
Sale
Price
17.50
Quantity 975 -1.0%
Value US$17,062
Nicola Greenway Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
16.72
Quantity 34,603
Value US$578,562
Teresa Bitetti President, Global Oncology Business Unit
Transaction date
Proposed sale
Price
16.75
Quantity 54,210
Value US$908,019
Marcello Pignagnoli Agosti Interim Head, Strategy and Portfolio Development
Transaction date
Proposed sale
Price
16.75
Quantity 24,887
Value US$416,850
Nicola Greenway Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
16.75
Quantity 7,348
Value US$123,072
Andrew Plump President, Research & Development
Transaction date
Proposed sale
Price
16.75
Quantity 179,239
Value US$3,002,258
Gabriele Ricci Chief Data & Technology Officer Officer
Transaction date
Proposed sale
Price
16.75
Quantity 27,197
Value US$455,545
Julie Kim President and CEO
Transaction date
Proposed sale
Price
16.75
Quantity 96,558
Value US$1,617,344
Giles Platford President, International Business Unit
Transaction date
Proposed sale
Price
16.75
Quantity 33,696
Value US$564,406
Elaine Shannon President, Global Supply & Quality
Transaction date
Proposed sale
Price
16.75
Quantity 4,319
Value US$72,351
Natalie Furney Global General Counsel
Transaction date
Proposed sale
Price
16.75
Quantity 33,454
Value US$560,351
Lauren Rusckowski Duprey Chief Transformation Officer Officer
Transaction date
Proposed sale
Price
16.75
Quantity 51,579
Value US$863,947
Awny Farajallah Chief Medical Officer Officer
Transaction date
Proposed sale
Price
16.75
Quantity 15,188
Value US$254,399
Rhonda Pacheco President, US Business Unit and US Country Head
Transaction date
Proposed sale
Price
16.75
Quantity 18,316
Value US$306,789
Ramy Riad President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
16.75
Quantity 7,889
Value US$132,149
Lauren Rusckowski Duprey Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
14.22
Quantity 29,619
Value US$421,182
Teresa Marie Bitetti President, Global Oncology Business Unit
Transaction date
Proposed sale
Price
14.28
Quantity 87,023
Value US$1,242,688
Giles Richard Platford President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
14.31
Quantity 58,421
Value US$836,005
Christophe Pierre Weber Chief Executive Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 34,857
Value US$537,495
Akiko Amakawa Corporate Strategy Officer & CEO Chief of Staff Officer
Transaction date
Proposed sale
Price
15.42
Quantity 5,608
Value US$86,475
Elaine Mary Shannon Global Quality Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 4,477
Value US$69,035
Marcello Pignagnoli Agosti Global Business Development Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 18,622
Value US$287,151
Gabriele Ricci Chief Data & Technology Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 26,874
Value US$414,397
Lauren Rusckowski Duprey Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 40,919
Value US$630,971
Thomas Wozniewski Global Manufacturing & Supply Officer Officer
Transaction date
Proposed sale
Price
15.42
Quantity 6,136
Value US$94,617
Julie Kim President, US Business Unit
Transaction date
Proposed sale
Price
15.42
Quantity 58,559
Value US$902,980
Andrew Plump President, Research & Development
Transaction date
Proposed sale
Price
15.42
Quantity 169,313
Value US$2,610,806
Giles Richard Platford President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
15.42
Quantity 28,552
Value US$440,272
Teresa Marie Bitetti President, Global Oncology Business Unit
Transaction date
Proposed sale
Price
15.42
Quantity 52,649
Value US$811,848
Ramona A Sequeira President, Global Portfolio Division
Transaction date
Proposed sale
Price
15.42
Quantity 102,972
Value US$1,587,828
Giles Richard Platford President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
14.94
Quantity 19,073
Value US$284,951
Thomas Wozniewski Global Manufacturing & Supply Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 4,533
Value US$59,745
Teresa Marie Bitetti President, Global Oncology Business Unit
Transaction date
Proposed sale
Price
13.18
Quantity 38,479
Value US$507,153
Ramona A Sequeira President, Global Portfolio Division
Transaction date
Proposed sale
Price
13.18
Quantity 74,654
Value US$983,940
Marcello Pignagnoli Agosti Global Business Development Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 10,674
Value US$140,683
Lauren Rusckowski Duprey Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 27,603
Value US$363,808
Julie Kim President, US Business Unit
Transaction date
Proposed sale
Price
13.18
Quantity 37,219
Value US$490,546
Giles Richard Platford President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
13.18
Quantity 20,721
Value US$273,103
Gabriele Ricci Chief Data & Technology Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 6,132
Value US$80,820
Elaine Mary Shannon Global Quality Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 4,612
Value US$60,786
Christophe Pierre Weber Chief Executive Officer Officer
Transaction date
Proposed sale
Price
13.18
Quantity 14,890
Value US$196,250
Andrew Plump President, Research & Development
Transaction date
Proposed sale
Price
13.18
Quantity 121,125
Value US$1,596,428
Akiko Amakawa Corporate Strategy Officer & CEO Chief of Staff Officer
Transaction date
Proposed sale
Price
13.18
Quantity 6,048
Value US$79,713
Thomas Wozniewski Global Manufacturing & Supply Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 4,789
Value US$74,134
Teresa Marie Bitetti President, Global Oncology Business Unit
Transaction date
Proposed sale
Price
15.48
Quantity 46,424
Value US$718,645
Ramona A Sequeira President, Global Portfolio Division
Transaction date
Proposed sale
Price
15.48
Quantity 68,184
Value US$1,055,490
Mwana Lugogo Chief Ethics & Compliance Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 2,045
Value US$31,654
Marcello Pignagnoli Agosti Global Business Development Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 10,522
Value US$162,874
Lauren Duprey Chief Human Resources Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 10,732
Value US$166,131
Julie Kim President, US Business Unit
Transaction date
Proposed sale
Price
15.48
Quantity 29,403
Value US$455,154
Giles Richard Platford President, Plasma-Derived Therapies Business Unit
Transaction date
Proposed sale
Price
15.48
Quantity 24,394
Value US$377,620
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-15 2026-09-14 S Sale
Duprey Lauren Rusckowski

Chief Transformation Officer

Officer
72,868 -24.6%
456.17
US$1,726,405 		72,868 -24.6% 456.17 US$1,726,405
2026-09-10 2026-09-10 PrS Proposed sale
Lauren Rusckowski Duprey

Chief Transformation Officer

Officer
91,377
250.66
US$4,551,337 		91,377 250.66 US$4,551,337
2026-09-03 2026-09-02 PlS Planned sale
Plump Andrew Stewart

President, R&D

Executive Director
68,583 +3.6%
250.92
US$3,511,874 		68,583 +3.6% 250.92 US$3,511,874
2026-09-02 2026-09-02 PrS Proposed sale
Plump Andrew Stewart

Officer

Officer
1,000
18.49
US$100,000 		1,000 18.49 US$100,000
2026-08-21 2026-08-19 PlS Planned sale
Plump Andrew Stewart

President, R&D

Executive Director
19,651 -7.0%
18.49
US$363,347 		19,651 -7.0% 18.49 US$363,347
2026-08-19 2026-08-19 PrS Proposed sale
Plump Andrew Stewart

Officer

Officer
19,651
18.49
US$363,348 		19,651 18.49 US$363,348
2026-08-19 2026-08-18 S Sale
Greenway Nicola Deidre Petal

Chief Human Resources Officer

Officer
12,980 -24.5%
18.11
US$235,118 		12,980 -24.5% 18.11 US$235,118
2026-08-14 2026-08-14 PrS Proposed sale
Nicola Greenway

Chief Human Resources Officer

Officer
12,980
17.39
US$225,722 		12,980 17.39 US$225,722
2026-08-12 2026-08-11 S Sale
Shannon Elaine Mary

Pres., Global Supply & Quality

Officer
20,363 -23.2%
17.55
US$357,371 		20,363 -23.2% 17.55 US$357,371
2026-08-10 2026-08-11 PrS Proposed sale
Elaine Shannon

President, Global Supply & Quality
20,363
17.45
US$355,334 		20,363 17.45 US$355,334
2026-08-12 2026-08-10 S Sale
Ibrahim Ramy Riad Ahmed

President, PDT BU

Officer
7,277 -6.6%
17.10
US$124,437 		7,277 -6.6% 17.10 US$124,437
2026-08-12 2026-08-10 S Sale
Farajallah Awny Samaan Botros

Chief Medical Officer

Officer
14,006 -10.8%
17.10
US$239,503 		14,006 -10.8% 17.10 US$239,503
2026-08-12 2026-08-10 S Sale
Duprey Lauren Rusckowski

Chief Transformation Officer

Officer
47,586 -17.4%
17.10
US$813,721 		47,586 -17.4% 17.10 US$813,721
2026-08-12 2026-08-10 S Sale
Pacheco Rhonda Janice

President, U.S. Business Unit

Officer
16,901 -8.5%
17.10
US$289,007 		16,901 -8.5% 17.10 US$289,007
2026-08-12 2026-08-10 S Sale
Plump Andrew Stewart

President, R&D

Executive Director
165,393 -17.7%
17.10
US$2,828,220 		165,393 -17.7% 17.10 US$2,828,220
2026-08-12 2026-08-10 S Sale
Pignagnoli Agosti Marcello

Head, Strat. & Port. Dev

Officer
22,957 -11.5%
17.10
US$392,565 		22,957 -11.5% 17.10 US$392,565
2026-08-12 2026-08-10 S Sale
Bitetti Teresa Marie

President, OBU

Officer
50,012 -16.6%
17.10
US$855,205 		50,012 -16.6% 17.10 US$855,205
2026-08-12 2026-08-10 S Sale
Shannon Elaine Mary

Pres., Global Supply & Quality

Officer
3,978 -5.9%
17.10
US$68,024 		3,978 -5.9% 17.10 US$68,024
2026-08-12 2026-08-10 S Sale
Ricci Gabriele

Chief Data & Tech. Officer

Officer
25,088 -12.8%
17.10
US$429,005 		25,088 -12.8% 17.10 US$429,005
2026-08-12 2026-08-10 S Sale
Greenway Nicola Deidre Petal

Chief Human Resources Officer

Officer
6,774 -11.3%
17.10
US$115,835 		6,774 -11.3% 17.10 US$115,835
2026-08-12 2026-08-10 S Sale
Platford Giles Richard

President, IBU

Officer
31,083 -9.0%
17.10
US$531,519 		31,083 -9.0% 17.10 US$531,519
2026-08-12 2026-08-10 S Sale
Kim Julie So-Young

President and CEO

Executive Director
89,090 -18.5%
17.10
US$1,523,439 		89,090 -18.5% 17.10 US$1,523,439
2026-08-12 2026-08-10 S Sale
Furney Natalie Anne Marie

Global General Counsel

Officer
30,868 -13.1%
17.10
US$527,843 		30,868 -13.1% 17.10 US$527,843
2026-08-12 2026-08-10 S Sale
Greenway Nicola Deidre Petal

Chief Human Resources Officer

Officer
33,628 -36.0%
17.51
US$588,715 		33,628 -36.0% 17.51 US$588,715
2026-08-12 2026-08-10 S Sale
Greenway Nicola Deidre Petal

Chief Human Resources Officer

Officer
975 -1.0%
17.50
US$17,062 		975 -1.0% 17.50 US$17,062
2026-08-06 2026-08-07 PrS Proposed sale
Nicola Greenway

Chief Human Resources Officer

Officer
34,603
16.72
US$578,562 		34,603 16.72 US$578,562
2026-07-13 2026-07-13 PrS Proposed sale
Teresa Bitetti

President, Global Oncology Business Unit
54,210
16.75
US$908,019 		54,210 16.75 US$908,019
2026-07-13 2026-07-13 PrS Proposed sale
Marcello Pignagnoli Agosti

Interim Head, Strategy and Portfolio Development
24,887
16.75
US$416,850 		24,887 16.75 US$416,850
2026-07-13 2026-07-13 PrS Proposed sale
Nicola Greenway

Chief Human Resources Officer

Officer
7,348
16.75
US$123,072 		7,348 16.75 US$123,072
2026-07-13 2026-07-13 PrS Proposed sale
Andrew Plump

President, Research & Development
179,239
16.75
US$3,002,258 		179,239 16.75 US$3,002,258
2026-07-13 2026-07-13 PrS Proposed sale
Gabriele Ricci

Chief Data & Technology Officer

Officer
27,197
16.75
US$455,545 		27,197 16.75 US$455,545
2026-07-13 2026-07-13 PrS Proposed sale
Julie Kim

President and CEO
96,558
16.75
US$1,617,344 		96,558 16.75 US$1,617,344
2026-07-13 2026-07-13 PrS Proposed sale
Giles Platford

President, International Business Unit
33,696
16.75
US$564,406 		33,696 16.75 US$564,406
2026-07-13 2026-07-13 PrS Proposed sale
Elaine Shannon

President, Global Supply & Quality
4,319
16.75
US$72,351 		4,319 16.75 US$72,351
2026-07-13 2026-07-13 PrS Proposed sale
Natalie Furney

Global General Counsel
33,454
16.75
US$560,351 		33,454 16.75 US$560,351
2026-07-13 2026-07-13 PrS Proposed sale
Lauren Rusckowski Duprey

Chief Transformation Officer

Officer
51,579
16.75
US$863,947 		51,579 16.75 US$863,947
2026-07-13 2026-07-13 PrS Proposed sale
Awny Farajallah

Chief Medical Officer

Officer
15,188
16.75
US$254,399 		15,188 16.75 US$254,399
2026-07-13 2026-07-13 PrS Proposed sale
Rhonda Pacheco

President, US Business Unit and US Country Head
18,316
16.75
US$306,789 		18,316 16.75 US$306,789
2026-07-13 2026-07-13 PrS Proposed sale
Ramy Riad

President, Plasma-Derived Therapies Business Unit
7,889
16.75
US$132,149 		7,889 16.75 US$132,149
2025-12-09 2025-12-09 PrS Proposed sale
Lauren Rusckowski Duprey

Chief Human Resources Officer

Officer
29,619
14.22
US$421,182 		29,619 14.22 US$421,182
2025-12-05 2025-12-05 PrS Proposed sale
Teresa Marie Bitetti

President, Global Oncology Business Unit
87,023
14.28
US$1,242,688 		87,023 14.28 US$1,242,688
2025-12-04 2025-12-04 PrS Proposed sale
Giles Richard Platford

President, Plasma-Derived Therapies Business Unit
58,421
14.31
US$836,005 		58,421 14.31 US$836,005
2025-07-09 2025-07-09 PrS Proposed sale
Christophe Pierre Weber

Chief Executive Officer

Officer
34,857
15.42
US$537,495 		34,857 15.42 US$537,495
2025-07-09 2025-07-09 PrS Proposed sale
Akiko Amakawa

Corporate Strategy Officer & CEO Chief of Staff

Officer
5,608
15.42
US$86,475 		5,608 15.42 US$86,475
2025-07-09 2025-07-09 PrS Proposed sale
Elaine Mary Shannon

Global Quality Officer

Officer
4,477
15.42
US$69,035 		4,477 15.42 US$69,035
2025-07-09 2025-07-09 PrS Proposed sale
Marcello Pignagnoli Agosti

Global Business Development Officer

Officer
18,622
15.42
US$287,151 		18,622 15.42 US$287,151
2025-07-09 2025-07-09 PrS Proposed sale
Gabriele Ricci

Chief Data & Technology Officer

Officer
26,874
15.42
US$414,397 		26,874 15.42 US$414,397
2025-07-09 2025-07-09 PrS Proposed sale
Lauren Rusckowski Duprey

Chief Human Resources Officer

Officer
40,919
15.42
US$630,971 		40,919 15.42 US$630,971
2025-07-09 2025-07-09 PrS Proposed sale
Thomas Wozniewski

Global Manufacturing & Supply Officer

Officer
6,136
15.42
US$94,617 		6,136 15.42 US$94,617
2025-07-09 2025-07-09 PrS Proposed sale
Julie Kim

President, US Business Unit
58,559
15.42
US$902,980 		58,559 15.42 US$902,980
2025-07-09 2025-07-09 PrS Proposed sale
Andrew Plump

President, Research & Development
169,313
15.42
US$2,610,806 		169,313 15.42 US$2,610,806
2025-07-09 2025-07-09 PrS Proposed sale
Giles Richard Platford

President, Plasma-Derived Therapies Business Unit
28,552
15.42
US$440,272 		28,552 15.42 US$440,272
2025-07-09 2025-07-09 PrS Proposed sale
Teresa Marie Bitetti

President, Global Oncology Business Unit
52,649
15.42
US$811,848 		52,649 15.42 US$811,848
2025-07-09 2025-07-09 PrS Proposed sale
Ramona A Sequeira

President, Global Portfolio Division
102,972
15.42
US$1,587,828 		102,972 15.42 US$1,587,828
2024-08-22 2024-08-23 PrS Proposed sale
Giles Richard Platford

President, Plasma-Derived Therapies Business Unit
19,073
14.94
US$284,951 		19,073 14.94 US$284,951
2024-07-10 2024-07-11 PrS Proposed sale
Thomas Wozniewski

Global Manufacturing & Supply Officer

Officer
4,533
13.18
US$59,745 		4,533 13.18 US$59,745
2024-07-10 2024-07-11 PrS Proposed sale
Teresa Marie Bitetti

President, Global Oncology Business Unit
38,479
13.18
US$507,153 		38,479 13.18 US$507,153
2024-07-10 2024-07-11 PrS Proposed sale
Ramona A Sequeira

President, Global Portfolio Division
74,654
13.18
US$983,940 		74,654 13.18 US$983,940
2024-07-10 2024-07-11 PrS Proposed sale
Marcello Pignagnoli Agosti

Global Business Development Officer

Officer
10,674
13.18
US$140,683 		10,674 13.18 US$140,683
2024-07-10 2024-07-11 PrS Proposed sale
Lauren Rusckowski Duprey

Chief Human Resources Officer

Officer
27,603
13.18
US$363,808 		27,603 13.18 US$363,808
2024-07-10 2024-07-11 PrS Proposed sale
Julie Kim

President, US Business Unit
37,219
13.18
US$490,546 		37,219 13.18 US$490,546
2024-07-10 2024-07-11 PrS Proposed sale
Giles Richard Platford

President, Plasma-Derived Therapies Business Unit
20,721
13.18
US$273,103 		20,721 13.18 US$273,103
2024-07-10 2024-07-11 PrS Proposed sale
Gabriele Ricci

Chief Data & Technology Officer

Officer
6,132
13.18
US$80,820 		6,132 13.18 US$80,820
2024-07-10 2024-07-11 PrS Proposed sale
Elaine Mary Shannon

Global Quality Officer

Officer
4,612
13.18
US$60,786 		4,612 13.18 US$60,786
2024-07-10 2024-07-11 PrS Proposed sale
Christophe Pierre Weber

Chief Executive Officer

Officer
14,890
13.18
US$196,250 		14,890 13.18 US$196,250
2024-07-10 2024-07-11 PrS Proposed sale
Andrew Plump

President, Research & Development
121,125
13.18
US$1,596,428 		121,125 13.18 US$1,596,428
2024-07-10 2024-07-11 PrS Proposed sale
Akiko Amakawa

Corporate Strategy Officer & CEO Chief of Staff

Officer
6,048
13.18
US$79,713 		6,048 13.18 US$79,713
2023-07-10 2023-07-11 PrS Proposed sale
Thomas Wozniewski

Global Manufacturing & Supply Officer

Officer
4,789
15.48
US$74,134 		4,789 15.48 US$74,134
2023-07-10 2023-07-11 PrS Proposed sale
Teresa Marie Bitetti

President, Global Oncology Business Unit
46,424
15.48
US$718,645 		46,424 15.48 US$718,645
2023-07-10 2023-07-11 PrS Proposed sale
Ramona A Sequeira

President, Global Portfolio Division
68,184
15.48
US$1,055,490 		68,184 15.48 US$1,055,490
2023-07-10 2023-07-11 PrS Proposed sale
Mwana Lugogo

Chief Ethics & Compliance Officer

Officer
2,045
15.48
US$31,654 		2,045 15.48 US$31,654
2023-07-10 2023-07-11 PrS Proposed sale
Marcello Pignagnoli Agosti

Global Business Development Officer

Officer
10,522
15.48
US$162,874 		10,522 15.48 US$162,874
2023-07-10 2023-07-11 PrS Proposed sale
Lauren Duprey

Chief Human Resources Officer

Officer
10,732
15.48
US$166,131 		10,732 15.48 US$166,131
2023-07-10 2023-07-11 PrS Proposed sale
Julie Kim

President, US Business Unit
29,403
15.48
US$455,154 		29,403 15.48 US$455,154
2023-07-10 2023-07-11 PrS Proposed sale
Giles Richard Platford

President, Plasma-Derived Therapies Business Unit
24,394
15.48
US$377,620 		24,394 15.48 US$377,620
Explore more

More insider trading research around Takeda Pharmaceutical Co Ltd

More insider trades in JP
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity